Issue Briefs

Issue Brief 6 - FDA Approves SEDASYS Device

Thursday, October 3, 2013

 

FDA Approves SEDASYS Device ( HTML | PDF  )

In recent years, Ethicon Endo-Surgery, Inc., a Johnson & Johnson subsidiary, has developed a Computer-Assisted Personalized Sedation (CAPS) product called SEDASYS, which administers a sedative (propofol) to patients undergoing certain procedures, including colonoscopies. On May 3, 2013, the U.S. Food and Drug Administration (FDA) approved the use of this device in limited medical cases after it was originally denied by the agency in April 2010. SEDASYS deployment and use is expected to begin in 2014.

 

Issue Brief 5 - The Impact of Health Insurance Reform on Colorectal Cancer

Monday, June 10, 2013

 

The Impact of Health Insurance Reform on Colorectal Cancer ( HTML | PDF )

Preventing Colorectal Cancer, a not-for-profit oganization, encourages policymakers, health officials, health plan executives and others to support colonoscopies as the gold standard colorectal cancer screening method. Health insurance reform has significantly changed the level of access that many Americans have to colorectal cancer screening. This issue brief is one in a series of publications describing what actions we can take together to make a difference and help patients navigate the waters of recent health insurance reform.

 

Issue Brief 4 - Why We Need Pricing Transparency

Monday, November 26, 2012

 

Why We Need Pricing Transparency( HTML | PDF )

Preventing Colorectal Cancer, a not-for-profit oganization, strives to educate the public on all aspects of colorectal cancer screening through colonoscopy—why it’s important, how to get it done, and how much it will cost? Patients need to know the price of the procedure and related expenses, including which part of the process is covered by insurance. Price transparency is an important public policy goal for individuals and providers, as well as their communities to ensure patients are receiving the best value for the dollar.

 

Issue Brief 3 - Health Insurers Should Cover Propofol Sedation

Wednesday, July 25, 2012

 

Health Insurers Should Cover Propofol Sedation During Colonoscopy Procedures ( HTML | PDF )

Health insurers should cover the most effective screening procedures available to prevent colon cancer. Most leading experts now agree an important adjunct to a traditional colonoscopy is offering the sedation option of propofol during the screening procedure.

 

Issue Brief 2 - The Benefit of Propofol

Tuesday, May 15, 2012

 

The Benefit of Propofol ( HTML | PDF )

Preventing Colorectal Cancer encourages public policymakers to participate in a well-rounded and objective discussion regarding how and when propofol/Diprivan (propofol) should be administered for endoscopic sedation. With recent reports addressing both the benefits and abuse of propofol, it is important a national standard be established to improve colon cancer detection rates and clinical outcomes. Studies show that more precancerous polyps are detected and removed during screening colonoscopies when propofol is used to sedate patients.

 

Pages